Hims & Hers shares rally on results, despite continued GLP-1 drug shortage

Hims & Hers Health Inc. saw a surge in shares after raising its sales outlook due to increased demand for personalized care and weight-loss drugs. Despite popularity, drug shortages and competition remain a challenge, with executives highlighting ongoing supply constraints.